Medical Equipment

Long-Read Sequencing Market Growth Projection: Expected to Surpass $3.74 Billion by 2030 at 26.5% CAGR

February 6, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the worker heat stress monitoring wearable market from 2026–2035 with trusted insights from The Business Research Company

What total market size is anticipated for the Long-Read Sequencing Market in 2030?

The long-read sequencing market has experienced substantial expansion in recent years. Projections indicate it will advance from $1.15 billion in 2025 to $1.46 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 26.8%. This historical growth can be ascribed to factors such as the constraints of short-read sequencing, the expansion of genomics research, innovations in nanopore sequencing technology, the requirement for precise genome assembly, and an increase in funding within the life sciences sector.

The long-read sequencing market is anticipated to experience rapid expansion in the coming years. This market is projected to reach $3.74 billion by 2030, driven by a compound annual growth rate (CAGR) of 26.5%. Several factors are contributing to this expansion during the forecast period, including the increasing clinical use of long-read sequencing, decreasing sequencing expenses, the incorporation of AI-based analytical methods, broader application in oncology diagnostics, and the rise of population genomics initiatives. Key developments expected over this period encompass wider acceptance of long-read technologies, enhanced detection of structural variants, the proliferation of hybrid sequencing methods, growth in rare disease genomics research, and increased utilization in assembling complex genomes.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28259&type=smp

What Drivers Are Influencing Production Trends In The Long-Read Sequencing Market?

The escalating occurrence of genetic illnesses is projected to drive the expansion of the long-read sequencing market in the coming years. Genetic diseases are health conditions resulting from DNA alterations or mutations, which can be inherited or develop without prior family history, affecting an individual’s health, growth, or physiological processes. The increase in these conditions is attributable to enhanced public awareness and advancements in diagnostic technologies, which enable earlier and more precise detection of previously undiagnosed conditions. Long-read sequencing improves the management of genetic disorders by delivering highly accurate and thorough genomic insights, rendering it ideal for diagnosing intricate and rare conditions. It minimizes diagnostic ambiguity through the identification of structural variations and complex mutations, thereby improving personalized therapy and clinical judgment. For instance, in October 2024, as per the Cystic Fibrosis Trust, a UK-based national charity, there were 11,148 individuals living with cystic fibrosis (CF) in the UK in 2022, a figure that climbed to 11,318 in 2023. Thus, the growing prevalence of genetic diseases is propelling the growth of the long-read sequencing market.

Which Segment Groups Are Influencing The Long-Read Sequencing Market?

The long-read sequencing market covered in this report is segmented –

1) By Product And Service: Instruments Or Platforms, Consumables And Reagents, Services And Software

2) By Workflow: Pre-Sequencing, Sequencing, Data Analysis

3) By Technology Platform: Single Molecule Real-Time (SMRT) High-Fidelity (HiFi) Sequencing, Synthetic Long-Read Or Linked-Read, Hybrid And Other Emerging

4) By Application: Human Genomics And Rare-Disease Diagnostics, Oncology And Liquid Biopsy, Metagenomics And Microbiome, Transcriptomics, Agri Genomics And Plant Or Animal Breeding, Other Applications

5) By End User: Academic And Research Institutes, Hospitals And Clinics, Pharmaceutical And Biotechnology Companies, Other End-Uses

Subsegments:

1) By Instruments Or Platforms: Single-Molecule Real-Time (SMRT) Sequencers, Nanopore Sequencers

2) By Consumables And Reagents: Library Preparation Kits, Sample Preparation Kits, Sequencing Kits

3) By Services And Software: Sequencing Services, Data Analysis Services, Bioinformatics Software

What Trends Are Projected To Support The Growth Of The Long-Read Sequencing Market?

Leading companies in the long-read sequencing market are concentrating on developing innovative solutions, such as HiFi reads, to improve sequencing accuracy, detect intricate genetic variations, and accelerate genomic research. High-fidelity (HiFi) reads refer to lengthy DNA sequences generated by specific long-read sequencing technologies, offering both extended read lengths and very low error rates, which enables the accurate identification of complex genetic variants and structural variations. As an illustration, in November 2024, Pacific Biosciences of California Inc., a US-based biotechnology company, introduced a Vega system, its inaugural benchtop long-read sequencing platform engineered for quicker and more accessible genomic analysis. This device is a compact, affordable benchtop long-read sequencer that provides highly accurate HiFi data with 99.9% read accuracy. It supports fast, versatile sequencing for uses such as RNA, targeted, and small genome sequencing, thereby extending advanced genomics capabilities to a greater number of laboratories. The Vega system simplifies workflows with its integrated computing and straightforward operation, allowing researchers to efficiently uncover complex genetic insights.

Who Are The Major Companies Operating In The Long-Read Sequencing Market?

Major companies operating in the long-read sequencing market are Thermo Fisher Scientific Inc., Agilent Technologies Inc., Revvity Inc., Bio-Rad Laboratories Inc., BGI Genomics Co. Ltd., Novogene Co. Ltd., Takara Bio Inc., Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., New England Biolabs Inc., Roche Sequencing Solutions Inc., The Garvan Institute, Element Biosciences Inc., Eurofins Genomics, CD Genomics, BaseClear B.V, France Génomique, GrandOmics Biosciences Co. Ltd., Future Genomics Technologies B.V., MicrobesNG

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/long-read-sequencing-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Long-Read Sequencing Market?

North America was the largest region in the long-read sequencing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the long-read sequencing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Long-Read Sequencing Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=28259&type=smp

Browse Through More Reports Similar to the Global Long-Read Sequencing Market 2026, By The Business Research Company

Next Generation Sequencing Market 2026

https://www.thebusinessresearchcompany.com/report/next-generation-sequencing-market

Dna Sequencing Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/dna-sequencing-global-market-report

Protein Sequencing Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/protein-sequencing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795